(Q41431445)

30 September 2017

1 reference

title

Mutations of the X region of hepatitis B virus and their clinical implications (English)

1 reference

30 September 2017

1 reference

Uchida T

1

1 reference

30 September 2017

Saitoh T

series ordinal

2

1 reference

30 September 2017

Shinzawa H

series ordinal

3

1 reference

30 September 2017

publication date

1 April 1997

1 reference

30 September 2017

published in

Pathology International

1 reference

30 September 2017

volume

47

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

183-193

1 reference

Genetic variations of the hepatitis B virus and their clinical relevance

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

X protein of hepatitis B virus resembles a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Functional organization of the hepatitis B virus enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.1997.TB04479.X

10.1111/J.1440-1827.1997.TB04479.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference